DLPIC
PTCT icon

Davide Leone & Partners Investment Company’s PTC Therapeutics PTCT Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-143,318
Closed -$6.9M – 14
2015
Q2 		$6.9M Sell
143,318
-202,529
-59% -$11.8M 0.71% 12
2015
Q1 		$21M Buy
+345,847
New +$21.1M 1.72% 15

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Davide Leone & Partners Investment Company's PTCT Position: Q3 2015 in Review

Davide Leone & Partners Investment Company sold out of PTC Therapeutics (PTCT) in Q3 2015, closing a stake of 143,318 shares — an estimated $6.9M sold.

Davide Leone & Partners Investment Company first reported a position in PTCT in Q1 2015 and held it in 2 quarters. The position peaked at $21M in Q1 2015. 157 funds tracked by Wall St. Rank hold PTCT as of Q3 2015.

  • Davide Leone & Partners Investment Company reported no remaining PTC Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 143,318 PTC Therapeutics shares in Q3 2015, an estimated $6.9M.
  • Davide Leone & Partners Investment Company first reported a position in PTC Therapeutics in Q1 2015 and held it in 2 quarters.
  • Davide Leone & Partners Investment Company's PTC Therapeutics position peaked at $21M in Q1 2015.
  • 157 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2015.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2015, filed 16 Nov 2015.